Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes.

Marathias, Katerina P; Lambadiari, Vaia A; Markakis, Konstantinos P; Vlahakos, Vassilios D; Bacharaki, Dimitra; Raptis, Athanasios E; Dimitriadis, George D; Vlahakos, Demetrios V

Marathias, Katerina P; Lambadiari, Vaia A; Markakis, Konstantinos P; Vlahakos, Vassilios D; Bacharaki, Dimitra; Raptis, Athanasios E; Dimitriadis, George D; Vlahakos, Demetrios V.

Afiliação

Marathias KP; Onassis Cardiac Surgery Center, Athens, Greece.
Lambadiari VA; 2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Markakis KP; 2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Vlahakos VD; Department of Pulmonary and Critical Care Services, Evangelismos Hospital, Athens, Greece.
Bacharaki D; 2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Raptis AE; 2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Dimitriadis GD; 2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Vlahakos DV; 2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece, vlahakos@otenet.gr.

Am J Nephrol ; 51(5): 349-356, 2020.

Article em En | MEDLINE | ID: mdl-32241009

Assuntos

Anemia/prevenção & controle; Diabetes Mellitus Tipo 2/tratamento farmacológico; Eritropoetina/metabolismo; Hipertensão/tratamento farmacológico; Sistema Renina-Angiotensina/efeitos dos fármacos; Anemia/sangue; Anemia/metabolismo; Antagonistas de Receptores de Angiotensina/farmacologia; Antagonistas de Receptores de Angiotensina/uso terapêutico; Inibidores da Enzima Conversora de Angiotensina/farmacologia; Inibidores da Enzima Conversora de Angiotensina/uso terapêutico; Glicemia/metabolismo; Diabetes Mellitus Tipo 2/sangue; Diabetes Mellitus Tipo 2/complicações; Nefropatias Diabéticas/sangue; Eritropoese/efeitos dos fármacos; Hematócrito; Hemoglobinas/análise; Humanos; Hipertensão/sangue; Hipertensão/complicações; Túbulos Renais/efeitos dos fármacos; Túbulos Renais/metabolismo; Reabsorção Renal/efeitos dos fármacos; Transportador 2 de Glucose-Sódio/metabolismo; Inibidores do Transportador 2 de Sódio-Glicose/farmacologia; Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico

Palavras-chave

Angiotensin converting enzyme inhibitors; Angiotensin receptor blockers; Haemoglobin; Hematocrit; Sodium-glucose cotransporter-2 inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Renina-Angiotensina / Eritropoetina / Diabetes Mellitus Tipo 2 / Hipertensão / Anemia Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google